Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Ownership Breakdown Vir Biotechnology Inc. VIR

Vir Biotechnology Inc is a commercial-stage immunology company focused on treating and preventing infectious diseases. It has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA, through internal development, collaborations, and acquisitions. The company's pipeline consists of product candidates targeting hepatitis B virus, or HBV, influenza A, human immunodeficiency virus, or HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue and license revenue.


Top institutional share ownership of Vir Biotechnology Inc

Name Shares Shares % change Value Value % change
Sb Investment Advisers (uk) Ltd 22,216,644 0.0% $571,412 -38.6%
Vanguard Group Inc 7,758,397 5.8% $199,546 -35.0%
Temasek Holdings (Private) Ltd 5,602,553 1.2% $144,098 -37.9%
BlackRock Inc. 5,396,184 1.7% $138,790 -37.6%
Millennium Management Llc 4,748,194 390.6% $122,124 201.4%
Capital International Investors 4,329,516 -21.4% $111,355 -51.7%
State Street Corp 4,193,764 65.9% $107,864 1.9%
Baillie Gifford & Co 3,930,852 -0.4% $100,119 -1.4%
Alliancebernstein L.p. 3,091,105 18.0% $79,503 -27.6%
XBI - SPDR(R) S&P(R) Biotech ETF 2,731,673 116.7% $70,259 33.1%

Top institutional buyers of Vir Biotechnology Inc

Name Shares % change Value % change Shares Value
Millennium Management Llc 390.6% 201.4% 4,748,194 $122,124
Bill & Melinda Gates Foundation 130.0% 41.2% 1,559,142 $40,100
XBI - SPDR(R) S&P(R) Biotech ETF 116.7% 33.1% 2,731,673 $70,259
State Street Corp 65.9% 1.9% 4,193,764 $107,864
Nuveen Asset Management, LLC 27.5% -22.9% 790,664 $20,028
Alliancebernstein L.p. 18.0% -27.6% 3,091,105 $79,503
Avidity Partners Management LP 11.4% -31.6% 780,000 $20,062
QUASX - AB Small Cap Growth Portfolio Class A 10.2% -34.7% 1,055,527 $21,480
Vanguard Group Inc 5.8% -35.0% 7,758,397 $199,546
Charles Schwab Investment Management Inc 2.6% -37.0% 745,328 $19,170

Top institutional sellers of Vir Biotechnology Inc

Name Shares % change Value % change Shares Value
Capital International Investors -21.4% -51.7% 4,329,516 $111,355
VISGX - Vanguard Small-Cap Growth Index Fund Investor Shares -3.5% -40.7% 1,189,122 $30,584
IWM - iShares Russell 2000 ETF -2.5% -40.1% 1,367,642 $35,176
NAESX - Vanguard Small-Cap Index Fund Investor Shares -0.5% -38.9% 1,968,008 $50,617
Baillie Gifford & Co -0.4% -1.4% 3,930,852 $100,119
ANWPX - NEW PERSPECTIVE FUND Class A -0.4% -38.8% 2,191,880 $56,375

Information provided by Fintel.io